Developing Precision Medicine in IBD: Peripheral Blood Eosinophilia Identifies Individuals With Worse Outcomes Following Initiation of Anti‐TNF Biologic Agents: 745. (October 2019) - Bettner, Weston; Althouse, Andrew; Rivers, Claudia Ramos; Schwartz, Marc; Proksell, Siobhan; Johnston, Elyse; Barrie, Arthur; Al Hashash, Jana; Harrison, Janet; Babichenko, Dmitriy; Tang, Gong; Koutroubakis, Ioannis; et al.